Sangrix Inc. carries no debt; cash flow comfortably covers obligations.

Sangrix Inc. has insufficient data to evaluate this check.

Sangrix Inc. has insufficient data to evaluate this check.

Sangrix Inc. has insufficient data to evaluate this check.

Sangrix Inc. has a net cash position, so leverage is healthy.

Sangrix Inc. carries no debt; interest obligations are fully covered.

Sangrix Inc.'s profit margin has decreased (4.18K%) in the last year from -606.95% to -25.95K%, signaling decreasing performance

Sangrix Inc. has insufficient data to evaluate this check.

Sangrix Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Sangrix Inc.'s return on equity of -731.64%, is lower than 15.00%, indicating bad performance

Sangrix Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Sangrix Inc. had positive net income in only 1 out of 5 years, indicating unstable earnings

Sangrix Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Sangrix Inc. has a free cash flow yield of 0.00%, which is below the 2.00% threshold, indicating limited cash return relative to market value

Sangrix Inc.'s yearly earnings has increased 74.98% since last year from $-17.53M to $-4.39M, signaling increasing performance

Sangrix Inc. has insufficient data to evaluate this check.

ROIC -16.59% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Sangrix Inc.'s 3-year revenue CAGR of -41.00% is negative, indicating declining revenue over the past 3 years

Sangrix Inc. had revenue growth in only 2 out of 5 years, indicating inconsistent revenue performance

Sangrix Inc. had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

Sangrix Inc. has insufficient data to evaluate this check.

Sangrix Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Sangrix Inc. has insufficient data to evaluate this check.

Sangrix Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Sangrix Inc. has insufficient data to evaluate this check.

Sangrix Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Sangrix Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

Sangrix Inc. has a price-to-sales ratio of 11.73x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue